BUSINESS
Aurobindo Pharma gains after its JV receives SEC recommendation for pneumococcal 15 valent vaccine
Aurobindo Pharma is currently trading at Rs. 442.75, up by 5.50 points or 1.26% from its previous closing of Rs. 437.25 on…
Aurobindo Pharma
BUSINESS
Aurobindo Pharma jumps on acquiring 51% stake in GLS Pharma
Aurobindo Pharma is currently trading at Rs. 583.95, up by 3.55 points or 0.61% from its previous closing of Rs. 580.40 on…
BUSINESS
Aurobindo Pharma moves up as its arm receives USFDA’s approval for Vasopressin Injection
Aurobindo Pharma is currently trading at Rs. 596.90, up by 3.60 points or 0.61% from its previous closing of Rs. 593.30 on…
BUSINESS
Aurobindo Pharma surges on acquiring business and certain assets of Veritaz Healthcare
Aurobindo Pharma is currently trading at Rs. 535.25, up by 6.60 points or 1.25% from its previous closing of Rs. 528.65 on…
BUSINESS
Aurobindo Pharma declines on reporting 28% fall in Q4 consolidated net profit
Aurobindo Pharma is currently trading at Rs. 532.75, down by 8.25 points or 1.52% from its previous closing of Rs. 541.00 on…
BUSINESS
Aurobindo Pharma jumps on getting DCGI’s permission to manufacture, distribute generic version of Molnupiravir
Aurobindo Pharma is currently trading at Rs. 728.80, up by 3.65 points or 0.50% from its previous closing of Rs. 725.15 on…
BUSINESS
Aurobindo Pharma’s arm receives USFDA’s approval for Cyclophosphamide Injection
Aurobindo Pharma’s subsidiary — Eugia Pharma Specialities (Eugia) has received a 505(b)(2) NDA approval from the U.S.Food & Drug Administration (USFDA) for…